《(二零一六)处于开发中的糖尿病药物》.pdf

1 Report M E D I C I N E S I N D E V E L O P M E N T F O R Diab t s P R E S E N T E D B Y A M E R I C A ’ S P H A R M A C E U T I C A L R E S E A R C H C O M P A N I E S Biopharmac utical Compani s D v loping a R cord 235 M dicin s to Tr at Diab t s and R lat d Conditions iabetes is in reasing at an alarming rate in M E D IC I N E S I N DEV E LO P M E NT FO R DIA B ET E S * Ameri a. Ea h day, approximately 4,110 people Dare diagnosed with diabetes. To help fight this Type 1 Diabetes 24 potentially devastating disease, Ameri a’s pharma eu ti al resear h and biote h nology ompanies are working on Type 2 Diabetes 144 235 new medi ines to treat diabetes and related onditions. A ll of the medi ines in this report are either in lini al Unspecified/Other Diabetes 23 trials or await ing approval by the U.S. Food and Drug Administration. Diabetes-Related 59 Conditions A ording to the Ameri an Diabetes Asso iation (ADA), diabetes affe ts more than 20 million Ameri ans—about *So me me d i ine s a re list e d in mo re t ha n o ne at e go ry. 8 per ent of the U.S. population—and a third are unaware they have t